Maternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brain

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 6, 2012, Pages 849-854

  Tuzun, Funda ^a   Kumral, Abdullah ^a   Dilek, Mustafa ^a   Ozbal, Seda ^a   Ergur, Bekir ^a   Yesilirmak, Didem Cemile ^a   Duman, Nuray ^a   Yilmaz, Osman ^a   Ozkan, Hasan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; DHA; EPA; Newborn; Periventricular leukomalacia

Indexed keywords

DOCOSAHEXAENOIC ACID; ENDOTOXIN; ICOSAPENTAENOIC ACID; LIPOPOLYSACCHARIDE; MYELIN BASIC PROTEIN; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN PERIVENTRICULAR LEUKOMALACIA; BRAIN PROTECTION; BRAIN WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; EMBRYO INDUCTION; FEMALE; GESTATIONAL AGE; HYPOMYELINATION; IMMUNOHISTOCHEMISTRY; MYELINATION; NEWBORN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION; WHITE MATTER INJURY;

ANIMALS; ANIMALS, NEWBORN; BRAIN; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; LEUKOENCEPHALOPATHIES; LIPOPOLYSACCHARIDES; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MOTHERS; NEUROPROTECTIVE AGENTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR;

EID: 84861031462     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.587917     Document Type: Article

References (44)

1. Kinney HC, Back SA. Human oligodendroglial development: Relationship to periventricular leukomalacia. Semin Pediatr Neurol 1998;5:180-189.
2. Volpe JJ. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 2005;116:221-225.
3. Jensen FE. Developmental factors regulating susceptibility to perinatal brain injury and seizures. Curr Opin Pediatr 2006;18:628-633.
4. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001;21:1302-1312.
5. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002;22:455-463. New York, Academic Press.
6. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000;20: 9235-9241.
7. Deng W, Pleasure J, Pleasure D. Progress in periventricular leukomalacia. Arch Neurol 2008;65:1291-1295.
8. Gibson RA, Neumann MA, Makrides M. Effect of dietary docosahexaenoic acid on brain composition and neural function in term infants. Lipids 1996;31(Suppl):S177-S181.
9. Innis SM. Fatty acids and early human development. Early Hum Dev 2007;83:761-766.
10. Carlson SE, Neuringer M. Polyunsaturated fatty acid status and neurodevelopment: A summary and critical analysis of the literature. Lipids 1999;34:171-178.
11. Cao D, Kevala K, Kim J, Moon HS, Jun SB, Lovinger D, Kim HY. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 2009;111:510-521.
12. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495-505.
13. Lu J, Jilling T, Li D, Caplan MS. Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Pediatr Res 2007;61:427-432.
14. Menard C, Patenaude C, Gagne AM, Massicotte G. AMPA receptormediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures. J Neurosci Res 2009;87:876-886.
15. German OL, Insua MF, Gentili C, Rotstein NP, Politi LE. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. J Neurochem 2006;98:1507-1520.
16. Suganuma H, Arai Y, Kitamura Y, Hayashi M, Okumura A, Shimizu T. Maternal docosahexaenoic acid-enriched diet prevents neonatal brain injury. Neuropathology 2010;30:597-605.
17. Cao DH, Xu JF, Xue RH, Zheng WF, Liu ZL. Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav 2004;79:651-659.
18. Bas O, Songur A, Sahin O, Mollaoglu H, Ozen OA, Yaman M, Eser O et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int 2007;50:548-554.
19. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: Implications for fatty acid requirements. Early Hum Dev 1980;4:121-129.
20. Martinez M. Developmental profiles of polyunsaturated fatty acids in the brain of normal infants and patients with peroxisomal diseases: Severe deficiency of docosahexaenoic acid in Zellweger's and pseudo-Zellweger's syndromes. World Rev Nutr Diet 1991;66:87-102.
21. Fernandes JS, Mori MA, Ekuni R, Oliveira RM, Milani H. Longterm treatment with fish oil prevents memory impairments but not hippocampal damage in rats subjected to transient, global cerebral ischemia. Nutr Res 2008;28:798-808.
22. Mizota A, Sato E, Taniai M, Adachi-Usami E, Nishikawa M. Protective effects of dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats. Invest Ophthalmol Vis Sci 2001;42:216-221.
23. Holguin S, Huang Y, Liu J, Wurtman R. Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav Brain Res 2008;191:11-16.
24. Calviello G, Palozza P, Franceschelli P, Bartoli GM. Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues. Lipids 1997;32:1075-1083.
25. Coluccia A, Borracci P, Renna G, Giustino A, Latronico T, Riccio P, Carratu MR. Developmental omega-3 supplementation improves motor skills in juvenile-adult rats. Int J Dev Neurosci 2009;27:599-605.
26. Cai Z, Pan ZL, Pang Y, Evans OB, Rhodes PG. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000;47:64-72.
27. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979;3:79-83.
28. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 2nd edn. New York, 1986.
29. Nyengaard JR. Stereologic methods and their application in kidney research. J Am Soc Nephrol 1999;10:1100-1123.
30. Berman DR, Liu YQ, Barks J, Mozurkewich E. Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation. Am J Obstet Gynecol 2010;202:469.e461-469.e466.
31. Berman DR, Liu Y, Barks J, Mozurkewich E. Treatment with docosahexaenoic acid after hypoxia-ischemia improves forepaw placing in a rat model of perinatal hypoxia-ischemia. Am J Obstet Gynecol 2010;203:385.e1-385.e5.
32. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689-10692.
33. Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001;276:16683-16689.
34. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH. Differential modulation of Toll-like receptors by fatty acids: Preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003;44:479-486.
35. De Smedt-Peyrusse V, Sargueil F, Moranis A, Harizi H, Mongrand S, Laye S. Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. J Neurochem 2008;105:296-307.
36. Chamnanvanakij S, Margraf LR, Burns D, Perlman JM. Apoptosis and white matter injury in preterm infants. Pediatr Dev Pathol 2002;5:184-189.
37. Folkerth RD. Neuropathologic substrate of cerebral palsy. J Child Neurol 2005;20:940-949.
38. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: A protective role for topiramate. J Neurosci 2004;24:4412-4420.
39. Manning SM, Talos DM, Zhou C, Selip DB, Park HK, Park CJ, Volpe JJ, Jensen FE. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 2008;28:6670-6678.
40. Zhang W, Hu X, Yang W, Gao Y, Chen J. Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions. Stroke 2010;41:2341-2347.
41. Mullen A, Loscher CE, Roche HM. Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. J Nutr Biochem 2010;21:444-450.
42. Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 2003;34:1006-1016.
43. Le HD, Meisel JA, de Meijer VE, Gura KM, Puder M. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2009;81:165-170.
44. Kawashima A, Harada T, Kami H, Yano T, Imada K, Mizuguchi K. Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells. J Nutr Biochem 2010;21: 268-277.